ABBV-744

2138861-99-9

Epigenetic Reader Domain

Epigenetics

CCNC (=O) C1=CC2=C (N1) C (=O) N (C=C2C3=C (C=CC (=C3) C (C) (C) O) OC4=C (C=C (C=C4C) F) C) C

C28H30FN3O4

ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2, BRD3 and BRD4. It is developed for treating AML and cancers.

3 years -20°C powder